Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

@inproceedings{Papageorgis2015TargetingIA,
  title={Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis},
  author={Panagiotis Papageorgis and Sait R. Ozturk and Arthur W Lambert and Christiana Neophytou and Alexandros Tzatsos and Chen Khuan Wong and Sam Thiagalingam and Andreas I. Constantinou},
  booktitle={Breast Cancer Research},
  year={2015}
}
IntroductionBasal-like breast cancer (BLBC) is an aggressive subtype often characterized by distant metastasis, poor patient prognosis, and limited treatment options. Therefore, the discovery of alternative targets to restrain its metastatic potential is urgently needed. In this study, we aimed to identify novel genes that drive metastasis of BLBC and to elucidate the underlying mechanisms of action.MethodsAn unbiased approach using gene expression profiling of a BLBC progression model and in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Interleukin-13 receptor alpha 2 expression in tumor cells is associated with reduced disease-free survival in patients with luminal subtype invasive breast cancer

  • Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • 2018
VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Protein interaction disruption in cancer

VIEW 3 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.

  • European journal of immunology
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL